1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 11 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1996A powerful new technique for isolating genes encoding cell surface antigens using retroviral expression cloningZannettino, A.; Rayner, J.; Ashman, L.; Gonda, T.; Simmons, P.
2003Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controlsHaynes, D.; Barg, E.; Crotti, T.; Holding, C.; Weedon, H.; Atkins, G.; Zannettino, A.; Ahern, M.; Coleman, M.; Roberts-Thomson, P.; Kraan, M.; Tak, P.; Smith, M.
2020HOPX regulates bone marrow-derived mesenchymal stromal cell fate determination via suppression of adipogenic gene pathwaysHng, C.H.; Camp, E.; Anderson, P.; Breen, J.; Zannettino, A.; Gronthos, S.
2008Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivoZannettino, A.; Paton, S.; Arthur, A.; Khor, F.; Itescu, S.; Gimble, J.; Gronthos, S.
2010Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissuesMenicanin, D.; Bartold, P.; Zannettino, A.; Gronthos, S.
2010Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cellsZannettino, A.; Paton, S.; Itescu, S.; Gronthos, S.
2007A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cellsGronthos, S.; Fitter, S.; Diamond, P.; Simmons, P.; Itescu, S.; Zannettino, A.
2010Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cellsGhosh, P.; Wu, J.; Shimmon, S.; Zannettino, A.; Gronthos, S.; Itescu, S.
2005Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cellsKortesidis, A.; Zannettino, A.; Isenmann, S.; Shi, S.; Lapidot, T.; Gronthos, S.
2007Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activityWhite, D.; Saunders, V.; Dang, P.; Engler, J.; Venables, A.; Zrim, S.; Zannettino, A.; Lynch, K.; Manley, P.; Hughes, T.

Discover